×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Case summary

-55-year-old male
-Hypertension, dyslipidemia
-Oct 2015: NSTEMI: long lesion in the context of myocardial bridging on mid LAD; FFR 0.75 à PCI on middle LAD with Biomatrix 3.5x11 mm, Stentys Xposition S 3.0-3.5x27 and 2.5-3.0x22 mm; postdilatation 3.0 NC 20 atm
-Dec 2016: In-stent occlusion (Stentys); unsuccessful PCI
-Possible Stentys fracture in mid LAD; ipsilateral epicardial collateral from CX
-SYNTAX score: 13.5
-J-CTO score: 2 (long occlusion; redo procedure)

Strategy

ACCESSES:

-Femoral 7F; XB 3.5 catheter, long sheath

APPROACHES:

-Antegrade true-to-true
-Corsair + Fielder FC
-OCT
-Scoring balloon; NC balloon
-Stenting
-Post dilatation with NC balloon
-OCT

Protocol: OptiRAY (Ioversol)

-Concentration: 350 mgl/mL
-Flow rate: 4mL/s
-Volume per injection: 14 ml
-Volume: 340 mL

 

Shooting date : 2017-01-26
Last update : 2021-06-09

OptiRAY® / Guerbet

Optiray® contrast agent is lower osmolar, lower viscosity and nonionic.

Ballon Scarifiant Actif Angiosculpt X / Philips

Cathéter à ballonnet d’abrasion pour Angioplastie coronaire transluminale percutanée (PTCA) enrobé d’un médicament

Suggestions

Tuesday, April 23rd 2024 from 05pm to 06:15pm (GMT+2)
Honolulu : Tuesday, April 23rd 2024 from 05am to 06:15am (GMT+2)
San Francisco : Tuesday, April 23rd 2024 from 08am to 09:15am (GMT+2)
New York : Tuesday, April 23rd 2024 from 11am to 12:15pm (GMT+2)
Buenos Aires : Tuesday, April 23rd 2024 from 12pm to 01:15pm (GMT+2)
Reykjavik : Tuesday, April 23rd 2024 from 03pm to 04:15pm (GMT+2)
London / Dublin : Tuesday, April 23rd 2024 from 04pm to 05:15pm (GMT+2)
Paris / Berlin : Tuesday, April 23rd 2024 from 05pm to 06:15pm (GMT+2)
Istanbul : Tuesday, April 23rd 2024 from 06pm to 07:15pm (GMT+2)
Moscou / Dubaï : Tuesday, April 23rd 2024 from 07pm to 08:15pm (GMT+2)
Bangkok : Tuesday, April 23rd 2024 from 10pm to 11:15pm (GMT+2)
Shanghai : Tuesday, April 23rd 2024 from 11pm to 12:15am (GMT+2)
Tokyo : Wednesday, April 24th 2024 from 12am to 01:15am (GMT+2)
Sydney : Wednesday, April 24th 2024 from 02am to 03:15am (GMT+2)
Wellington : Wednesday, April 24th 2024 from 04am to 05:15am (GMT+2)

From Access to Closure through Treatment:

How to Maximize Outcomes while Minimizing Impact

Share
Wednesday, October 4th 2023 from 06pm to 06:45pm (GMT+2)
Honolulu : Wednesday, October 4th 2023 from 06am to 06:45am (GMT+2)
San Francisco : Wednesday, October 4th 2023 from 09am to 09:45am (GMT+2)
New York : Wednesday, October 4th 2023 from 12pm to 12:45pm (GMT+2)
Buenos Aires : Wednesday, October 4th 2023 from 01pm to 01:45pm (GMT+2)
Reykjavik : Wednesday, October 4th 2023 from 04pm to 04:45pm (GMT+2)
London / Dublin : Wednesday, October 4th 2023 from 05pm to 05:45pm (GMT+2)
Paris / Berlin : Wednesday, October 4th 2023 from 06pm to 06:45pm (GMT+2)
Istanbul : Wednesday, October 4th 2023 from 07pm to 07:45pm (GMT+2)
Moscou / Dubaï : Wednesday, October 4th 2023 from 08pm to 08:45pm (GMT+2)
Bangkok : Wednesday, October 4th 2023 from 11pm to 11:45pm (GMT+2)
Shanghai : Thursday, October 5th 2023 from 12am to 12:45am (GMT+2)
Tokyo : Thursday, October 5th 2023 from 01am to 01:45am (GMT+2)
Sydney : Thursday, October 5th 2023 from 03am to 03:45am (GMT+2)
Wellington : Thursday, October 5th 2023 from 05am to 05:45am (GMT+2)

Guides de 1ère intention :

algorithme décisionnel de la lésion simple à la lésion complexe

Share
Wednesday, April 26th 2023 from 01pm to 02:30pm (GMT+2)
Honolulu : Wednesday, April 26th 2023 from 01am to 02:30am (GMT+2)
San Francisco : Wednesday, April 26th 2023 from 04am to 05:30am (GMT+2)
New York : Wednesday, April 26th 2023 from 07am to 08:30am (GMT+2)
Buenos Aires : Wednesday, April 26th 2023 from 08am to 09:30am (GMT+2)
Reykjavik : Wednesday, April 26th 2023 from 11am to 12:30pm (GMT+2)
London / Dublin : Wednesday, April 26th 2023 from 12pm to 01:30pm (GMT+2)
Paris / Berlin : Wednesday, April 26th 2023 from 01pm to 02:30pm (GMT+2)
Istanbul : Wednesday, April 26th 2023 from 02pm to 03:30pm (GMT+2)
Moscou / Dubaï : Wednesday, April 26th 2023 from 03pm to 04:30pm (GMT+2)
Bangkok : Wednesday, April 26th 2023 from 06pm to 07:30pm (GMT+2)
Shanghai : Wednesday, April 26th 2023 from 07pm to 08:30pm (GMT+2)
Tokyo : Wednesday, April 26th 2023 from 08pm to 09:30pm (GMT+2)
Sydney : Wednesday, April 26th 2023 from 10pm to 11:30pm (GMT+2)
Wellington : Thursday, April 27th 2023 from 12am to 01:30am (GMT+2)

CAMP LIVE CASE

European Session from Luzerner Kantonsspital

Share
Thursday, June 1st 2023 from 05pm to 06pm (GMT+2)
Honolulu : Thursday, June 1st 2023 from 05am to 06am (GMT+2)
San Francisco : Thursday, June 1st 2023 from 08am to 09am (GMT+2)
New York : Thursday, June 1st 2023 from 11am to 12pm (GMT+2)
Buenos Aires : Thursday, June 1st 2023 from 12pm to 01pm (GMT+2)
Reykjavik : Thursday, June 1st 2023 from 03pm to 04pm (GMT+2)
London / Dublin : Thursday, June 1st 2023 from 04pm to 05pm (GMT+2)
Paris / Berlin : Thursday, June 1st 2023 from 05pm to 06pm (GMT+2)
Istanbul : Thursday, June 1st 2023 from 06pm to 07pm (GMT+2)
Moscou / Dubaï : Thursday, June 1st 2023 from 07pm to 08pm (GMT+2)
Bangkok : Thursday, June 1st 2023 from 10pm to 11pm (GMT+2)
Shanghai : Thursday, June 1st 2023 from 11pm to 12am (GMT+2)
Tokyo : Friday, June 2nd 2023 from 12am to 01am (GMT+2)
Sydney : Friday, June 2nd 2023 from 02am to 03am (GMT+2)
Wellington : Friday, June 2nd 2023 from 04am to 05am (GMT+2)

The safe use of DCB in PCI:

from young to old patients

Share
Scroll Up